Trial Profile
Pilot open label clinical trial with abatacept in ankylosing spondylitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 04 Jun 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 25 Feb 2008 Status changed from initiated to recruiting.
- 27 Nov 2007 New trial record.